With a new ‘working group,’ HHS opens door to possibility of importing some drugs
WASHINGTON — The Trump administration is opening up the door to importing prescription drugs — at least in a limited number of cases.
The administration will form a working group to look at the idea of importing drugs from other countries in cases in which there is “a dramatic price increase for a drug produced by one manufacturer and not protected by patents or exclusivities,” Health and Human Services Secretary Alex Azar said early Thursday.
It’s an early step, but the idea behind it is one of the boldest the administration has yet proposed as it has laid out a series of ways to bring down the cost of prescription drugs. Although President Trump said on the campaign trail that he supports importing drugs from other countries as a way to lower prices for Americans, the notion has traditionally been more popular among Democrats. Independent Sen. Bernie Sanders of Vermont, the former presidential candidate, is one of its most vocal proponents. [...]health care costs health law policy intellectual property international market pharmaceuticals public health